J Rheumatol. 2023 Jun 15:jrheum.2023-0060 DOI: 10.3899/jrheum.2023-0060
An analysis of the California Lupus Epidemiology Study cohort demonstrated that more than a quarter of participants reported at least one medication cost concern, which was associated with worse patient-reported outcomes. These results reveal a potentially modifiable risk factor for poor outcomes rooted in the unaffordability of lupus care.
Investigators aimed to assess the association of self-reported medication cost concerns and PROs in a multiethnic lupus cohort in 334 participants. This included mean pain interference and fatigue, as well as the resulting impact of medication cost concerns on sleep disturbance and social roles/activities